National Peroxide restates FY26 results, reports Q1 FY27 earnings
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.7 pts more than Nifty Microcap 250 and 5.6 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide restated FY26 results after discovering an ERP error that understated raw material cost by Rs. 694.63 lakhs. Q1 FY27 revenue rose to Rs. 9,606.77 lakhs vs Rs. 8,568.29 lakhs YoY; PAT jumped to Rs. 660.89 lakhs vs Rs. 89.03 lakhs. Auditor gave Unmodified Opinion with Emphasis of Matter.
Restatement cuts FY26 profit by about Rs. 695 lakhs. Strong Q1 PAT jump YoY. Final dividend of Rs. 7 per share proposed.